Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hannah M Jones
Evaluation of the Antitumor Effects of C-Myc-Max Heterodimerization Inhibitor 100258-F4 in Ovarian Cancer Cells
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Related publications
SNORD89 Promotes Stemness Phenotype of Ovarian Cancer Cells by Regulating Notch1-C-Myc Pathway
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Antitumor Effects and Mechanisms of Dendritic Cells Stimulated by sCD40L on Ovarian Cancer Cells in Vitro
OncoTargets and Therapy
Oncology
Pharmacology
Activity of the Multikinase Inhibitor Dasatinib Against Ovarian Cancer Cells
British Journal of Cancer
Cancer Research
Oncology
Preclinical Evaluation of Antitumor Activity of the Proteasome Inhibitor MLN2238 (Ixazomib) in Hepatocellular Carcinoma Cells
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Effects of Isoliquiritigenin on Ovarian Cancer Cells
OncoTargets and Therapy
Oncology
Pharmacology
Antitumor Mechanism of Gold Nanoparticles in Ovarian Cancer
Science-Business eXchange
The Myc Negative Autoregulation Mechanism Requires Myc-Max Association and Involves the C-Myc P2 Minimal Promoter.
Molecular and Cellular Biology
Cell Biology
Molecular Biology
Abnormal Expression of C-Myc Oncogene in NK Cells in Patients With Cancer
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
C-Jun-Nh2-Kinase-1 Inhibition Leads to Antitumor Activity in Ovarian Cancer
Clinical Cancer Research
Cancer Research
Oncology
